Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation · 2020-05 · 26 (5) · e128-e133
DOI: 10.1016/j.bbmt.2020.01.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-05. Verfasst von Yanmin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology,…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
- Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: w…
- Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: h…
Förderung
- NCI NIH HHS
- National Natural Science Foundation of China
Zitieren
APA
Zhao, Y., Shi, J., Luo, Y., Gao, F., Tan, Y., Lai, X., Yu, J., Wei, G., & Huang, H. (2020). Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 26(5), e128-e133. https://doi.org/10.1016/j.bbmt.2020.01.012
Vancouver
Zhao Y, Shi J, Luo Y, Gao F, Tan Y, Lai X, et al. Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2020;26(5):e128-e133. doi:10.1016/j.bbmt.2020.01.012
BibTeX
@article{Zhao2020,
author = {Zhao, Yanmin and Shi, Jimin and Luo, Yi and Gao, Fei and Tan, Yamin and Lai, Xiaoyu and Yu, Jian and Wei, Guoqing and Huang, He},
title = {Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation},
journal = {Biology of Blood and Marrow Transplantation},
year = {2020},
volume = {26},
number = {5},
pages = {e128--e133},
doi = {10.1016/j.bbmt.2020.01.012}
}
EUVIMED